IRON — Disc Medicine Cashflow Statement
0.000.00%
- $1.35bn
- $1.00bn
- 44
- 25
- 48
- 33
Annual cashflow statement for Disc Medicine, fiscal year end - December 31st, millions except per share.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | |
Standards: | — | USG | USG | USG | USG |
Status: | fx Preliminary | Final | Final | Final | Final |
Net Income/Starting Line | — | -0.813 | -71.9 | -46.8 | -76.4 |
Depreciation | |||||
Non-Cash Items | — | -0.005 | 10.1 | 2.36 | 5.82 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | — | 0.401 | 1.86 | 2.13 | -2.95 |
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | — | -0.416 | -59.7 | -42.3 | -73.5 |
Capital Expenditures | — | — | -0.071 | -0.151 | -0.089 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | -121 | 0.415 | — | — |
Sale of Business | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | — | -121 | 0.344 | -0.151 | -0.089 |
Financing Cash Flow Items | — | -2.81 | 196 | 95.3 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | — | 122 | 191 | 149 | 239 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | — | 1.21 | 132 | 107 | 166 |